2007
DOI: 10.1111/j.1365-2222.2007.02851.x
|View full text |Cite
|
Sign up to set email alerts
|

Neurokinin‐1 receptor activation induces reactive oxygen species and epithelial damage in allergic airway inflammation

Abstract: Allergen challenge induces ROS in a tachykinin NK-1 receptor-dependent manner. Inhibition of the tachykinin NK-1 receptor reduces epithelial damage and subsequent remodelling in vivo. Therefore, patients may possibly benefit from treatment regime that includes radical scavengers or tachykinin NK-1 receptor antagonists.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2009
2009
2025
2025

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(12 citation statements)
references
References 44 publications
0
12
0
Order By: Relevance
“…To assess the physiological relevance of the in vitro ROS inhibitor findings, mice were treated with the ROS inhibitor NAc via i.n. administration as previously described (Springer et al, 2007). Similar to the monocyte cell line findings, treatment with NAc completely inhibited the generation of IL-1β in the BALF following influenza infection (Figure 5M).…”
Section: Resultsmentioning
confidence: 99%
“…To assess the physiological relevance of the in vitro ROS inhibitor findings, mice were treated with the ROS inhibitor NAc via i.n. administration as previously described (Springer et al, 2007). Similar to the monocyte cell line findings, treatment with NAc completely inhibited the generation of IL-1β in the BALF following influenza infection (Figure 5M).…”
Section: Resultsmentioning
confidence: 99%
“…These responses neutralize, hinder, and expel toxic materials, limiting damage to the delicate alveolar sacs. However, continued exposures can lead to exaggerated responses that compromise respiratory function (20,22). Reactive TIHs can compound pre-existing conditions.…”
mentioning
confidence: 99%
“…For example, they are notorious for triggering attacks in individuals with asthma (irritant-induced asthma) (23). The continual respiratory responses might be involved in the development of chronic airway diseases, including bronchitis and occupational asthma, and reactive airway dysfunction syndrome (20)(21)(22)(24)(25)(26)(27)(28)(29). Exaggerated sensory neuronal responses may contribute to the pulmonary edema and adult respiratory distress syndrome (ARDS) seen with high concentration exposure of TIHs (30,31).…”
mentioning
confidence: 99%
“…Together, an initial TRPA1 response to respiratory irritants, followed by secondary responses to inflammatory mediators, implicates TRPA1 in sensory processing and augmented dysregulation in airway diseases due to enduring inflammation and lung remodeling (Springer et al, 2007;Li et al, 2008). TRPA1 is also likely to mediate allergen-induced airway inflammation in patients with asthma, as demonstrated using trpa1 2/2 mice or by treatment with the selective TRPA1 inhibitor 2,3,acetamide], which reduces allergen-induced leukocyte infiltration, cytokine and mucus production, and airway hyper-responsiveness Raemdonck et al, 2012).…”
mentioning
confidence: 99%